Literature DB >> 16618833

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Jeong-a Kim1, Monica Montagnani, Kwang Kon Koh, Michael J Quon.   

Abstract

Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618833     DOI: 10.1161/CIRCULATIONAHA.105.563213

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  459 in total

1.  A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus.

Authors:  Maria Galán; Modar Kassan; Soo-Kyoung Choi; Megan Partyka; Mohamed Trebak; Daniel Henrion; Khalid Matrougui
Journal:  Hypertension       Date:  2012-06-04       Impact factor: 10.190

Review 2.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

3.  FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.

Authors:  Kyoichiro Tsuchiya; Jun Tanaka; Yu Shuiqing; Carrie L Welch; Ronald A DePinho; Ira Tabas; Alan R Tall; Ira J Goldberg; Domenico Accili
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

4.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

5.  Implication of vitamin A deficiency on vascular injury related to inflammation and oxidative stress. Effects on the ultrastructure of rat aorta.

Authors:  Laura V Gatica; Liliana B Oliveros; Matías F Pérez Díaz; Nora S Domínguez; Miguel W Fornes; María S Gimenez
Journal:  Eur J Nutr       Date:  2011-04-22       Impact factor: 5.614

6.  A new antihypertensive drug ameliorate insulin resistance.

Authors:  Yan-xia Liu
Journal:  Acta Pharmacol Sin       Date:  2012-04       Impact factor: 6.150

Review 7.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women.

Authors:  Baihui Xu; Jie Zhang; Yu Xu; Jieli Lu; Min Xu; Yuhong Chen; Yufang Bi; Guang Ning
Journal:  Front Med       Date:  2013-02-06       Impact factor: 4.592

Review 9.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

10.  Low-level laser irradiation modifies the effect of hyperglycemia on adhesion molecule levels.

Authors:  Krzysztof Góralczyk; Justyna Szymańska; Łukasz Gryko; Jacek Fisz; Danuta Rość
Journal:  Lasers Med Sci       Date:  2018-05-03       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.